SaraBarmettlerMD

Allergy & Immunology • Boston, MA

Physician

Join to view full profile

Dr. Barmettler is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Barmettler's full profile

Already have an account?

Office
55 Fruit St
Boston, MA 02114
Phone+1 617-726-3850

Fax+1 617-724-0239

Education & Training

Massachusetts General HospitalFellowship, Allergy and Immunology, 2015 - 2017
Yale-New Haven Medical CenterResidency, Internal Medicine, 2012 - 2015
University of Massachusetts Medical SchoolClass of 2012

Certifications & Licensure

ME State Medical License 2021 - 2026
MA State Medical License 2015 - 2025
NH State Medical License 2021 - 2025
RI State Medical License 2021 - 2024
American Board of Allergy and Immunology Allergy & Immunology
American Board of Internal Medicine Internal Medicine

Publications & Presentations

PubMed

54 citations
Common Variable Immunodeficiency Non-Infectious Disease Endotypes Redefined Using Unbiased Network Clustering in Large Electronic Datasets.
Jocelyn R. Farmer, Mei-Sing Ong, Sara Barmettler, Lael M. Yonker, Ramsay Fuleihan
Frontiers in Immunology. 2018-01-09
200 citations
Association of Immunoglobulin Levels, Infectious Risk, and Mortality With Rituximab and Hypogammaglobulinemia.
Sara Barmettler, Mei-Sing Ong, Jocelyn R. Farmer, Hyon K. Choi, Jolan E. Walter
JAMA Network Open. 2018-11-02
30 citations
Hypogammaglobulinemia after Chimeric Antigen Receptor (CAR) T-cell therapy: characteristics, management, and future directions.
Jeanette Wat, Sara Barmettler
The Journal of Allergy and Clinical Immunology. in Practice. 2021-10-28

Press Mentions

Association of Immunoglobulin Levels, Infectious Risk, and Mortality with Rituximab and HypogammaglobulinemiaNovember 2nd, 2018
Outpatient Chemo Desensitization Program Safe, Cuts TimeOctober 31st, 2017